Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Reexamination Certificate
2000-09-28
2009-12-08
Zeman, Robert A (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
C424S184100, C424S234100, C424S235100, C424S236100, C424S239100, C424S247100, C424S183100, C424S178100, C424S179100, C424S164100, C424S167100, C424S832000, C530S350000, C530S300000
Reexamination Certificate
active
07628992
ABSTRACT:
A chemical conjugate for treating a nerve cell related disorder is provided. This conjugate includes an active or inactive Clostridial toxin having specificity for a target nerve cell. The toxin is conjugated to a drug or other bioactive molecule without affecting the toxin's ability to enter the target nerve cell.
REFERENCES:
patent: 4594336 (1986-06-01), Bizzini
patent: 4713240 (1987-12-01), Wilkins et al.
patent: 5204097 (1993-04-01), Amon et al.
patent: 5437291 (1995-08-01), Pasricha et al.
patent: 5443976 (1995-08-01), Carroll
patent: 5512547 (1996-04-01), Johnson et al.
patent: 5562907 (1996-10-01), Amon
patent: 5585100 (1996-12-01), Mond et al.
patent: 5599539 (1997-02-01), Carroll et al.
patent: 5601823 (1997-02-01), Williams et al.
patent: 5650280 (1997-07-01), Stuart et al.
patent: 5674205 (1997-10-01), Pasricha et al.
patent: 5693476 (1997-12-01), Scheller
patent: 5719267 (1998-02-01), Carroll et al.
patent: 5721215 (1998-02-01), Aoki et al.
patent: 5736139 (1998-04-01), Kink et al.
patent: 5762934 (1998-06-01), Williams et al.
patent: 5814477 (1998-09-01), Williams et al.
patent: 5919665 (1999-07-01), Williams
patent: 5955368 (1999-09-01), Johnson et al.
patent: 5965699 (1999-10-01), Schmidt et al.
patent: 0254905 (1988-03-01), None
patent: 9400487 (1994-01-01), None
patent: 9421300 (1994-09-01), None
patent: 00/33880 (2000-06-01), None
De Paiva et al.,J. Biol. Chem, 268:20838 (1993).
Weller et al.,Eur. J. Biochem.182:649(1989).
Bizzini et al, Journal of Neurochemistry, 1977, vol. 28, pp. 529-542, “An Antigenic Polypeptide Fragment Isolated From Tetanus Toxin: Chemical Characterization, Binding To Gangliosides and Retrograde Axonal Transport in Various Neuron Systems”.
Dertzbaugh et al, Vaccine 14/6: 1538-44, 1996.
Thompson et al, Eur. J. Biochem. 189:73-81, 1990.
Kozaki et al, Microbiol, Immunol. 39/ 10: 767-774, 1995.
Pellizzari et al, Phil. Trans. R. Soc. Lond. 354: 259-268, 1999.
Aoki Kei Roger
Dolly James Oliver
Garst Michael Elwood
Wheeler Larry Allen
Fisher Carlos A.
Invent DCU Limited
Stout, UXA Buyan & Mullins, LLP
Zeman Robert A
LandOfFree
Modification of clostridial toxins for use as transport... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modification of clostridial toxins for use as transport..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modification of clostridial toxins for use as transport... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4082362